Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547638 · ClinicalTrials.gov registry record · Phase 2
Study to Show Equivalence of DERMABOND PROTAPE to DERMABOND HVD for Wound Closure
A Phase 2 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 2
- Development phase
- 216
- Enrollment target
NCT00547638 is a Phase 2 study that has completed, run by Ethicon. The registered enrollment target is 216 participants.
The verdict
NCT00547638, a Phase 2 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 216 participants
- Enrollment target
Study Summary
This is a multicenter, prospective, randomized controlled study for the purpose of comparing DERMABOND PROTAPE to DERMABOND HVD for closure of wounds in the Emergency Department. The objective of this study is to demonstrate whether the incidence of wound closure for DERMABOND PROTAPE is equivalent to that measured for DERMABOND HVD.
Interventions
- DEVICE cyanoacrylate with pressure sensitive mesh
- DEVICE cyanoacrylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547638
The ClinicalTrials.gov registry entry for NCT00547638 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cyanoacrylate with pressure sensitive mesh is the first listed.
NCT00547638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00547638 about?
NCT00547638 is a clinical study titled "Study to Show Equivalence of DERMABOND PROTAPE to DERMABOND HVD for Wound Closure". This is a multicenter, prospective, randomized controlled study for the purpose of comparing DERMABOND PROTAPE to DERMABOND HVD for closure of wounds in the Emergency Department. The objective of this study is to demonstrate whether the incidence of wound closure for DERMABOND PROTAPE is equivalent ...
What is the current status of trial NCT00547638?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 216 participants. The study started on 2007-08. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00547638?
The interventions under investigation include: cyanoacrylate with pressure sensitive mesh (DEVICE), cyanoacrylate (DEVICE).
Who is sponsoring clinical trial NCT00547638?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.